login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
Principia Biopharma Inc (PRNB) Stock News
NASDAQ:PRNB - Nasdaq -
100.05
+0.1 (+0.1%)
After market: 100.02
-0.03 (-0.03%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
PRNB Latest News, Press Relases and Analysis
All
Press Releases
5 years ago - By: Investor's Business Daily
- Mentions:
NVS
BIIB
SNY
MRK
...
Pharmaceutical Industry Leaders Target Cutting-Edge MS Treatments That Once Were 'Fantasy'
5 years ago - By: Bloomberg
Sanofi Is Said to Weigh Sale of Some Inflammation Assets
5 years ago - By: Seeking Alpha
dosing underway for Principia's rilzabrutinib mid-stage study in IgG4-related disease (NASDAQ:PRNB)
5 years ago - By: Johnson Fistel, LLP
- Mentions:
SNY
(PRNB) Alert: Johnson Fistel Investigates Proposed Sale of Principia Biopharma; Is $100 a Fair Price?
5 years ago - By: Halper Sadeh LLP
- Mentions:
VAR
PTI
LVGO
INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – PRNB, VAR, PTI, LVGO
5 years ago - By: Halper Sadeh LLP
- Mentions:
BLDR
PFNX
MVC
INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – PRNB, BLDR, PFNX, MVC
5 years ago - By: WeissLaw LLP
- Mentions:
PFNX
WeissLaw LLP Reminds PFNX and PRNB Shareholders About Its Ongoing Investigations
5 years ago - By: Halper Sadeh LLP
- Mentions:
MNTA
PTI
BLDR
SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – PRNB, MNTA, PTI, BLDR
5 years ago - By: Halper Sadeh LLP
- Mentions:
CBMG
MNTA
PTI
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – CBMG, PRNB, MNTA, PTI
5 years ago - By: Benzinga
- Mentions:
XBI
ACOR
CERS
EPIX
...
The Daily Biotech Pulse: Altimmune Reports Positive Preclinical Data For Intranasal COVID-19 Vaccine, AbbVie Licenses Morphic's Drug, Viveve Clinical Readout
5 years ago - By: Benzinga
- Mentions:
NOW
AAPL
ADBE
ADSK
...
Stocks That Hit 52-Week Highs On Monday
5 years ago - By: Barron's
- Mentions:
HD
XHB
SPX
LOW
...
Housing Numbers Rise, and Lowe’s and Home Depot Stock Follow
5 years ago - By: Investor's Business Daily
- Mentions:
AAPL
TSLA
NVDA
BABA
...
Apple, Tesla Drive Tech-Led Stock Market Rally; Nvidia, JD, Alibaba, Target Are Earnings Winners
5 years ago - By: Kahn Swick & Foti, LLC
PRINCIPIA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Principia Biopharma Inc. - PRNB
5 years ago - By: Zacks Investment Research
- Mentions:
JNJ
SNY
MNTA
J&J to Buy Momenta for $6.5B to Boost Autoimmune Presence
5 years ago - By: Zacks Investment Research
- Mentions:
JNJ
SNY
MNTA
Momenta Surges on Acquisition Deal With Johnson & Johnson
5 years ago - By: Halper Sadeh LLP
- Mentions:
ADI
CBMG
MNTA
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Mergers; Shareholders are Encouraged to Contact the Firm – ADI, CBMG, PRNB, MNTA
5 years ago - By: Barron's
- Mentions:
JNJ
MNTA
SNY
Johnson & Johnson Buys Biotech Momenta Pharmaceuticals for $6.5 Billion
5 years ago - By: Investor's Business Daily
- Mentions:
JNJ
MNTA
SNY
Johnson & Johnson To Acquire Momenta Pharmaceuticals For $6.5 Billion
5 years ago - By: Barron's
- Mentions:
DJIA
SPX
COMP
HD
...
Stocks Are Scuffling, but a ‘New Bull Market Still Offers Opportunities’
5 years ago - By: Halper Sadeh LLP
- Mentions:
MR
YIN
SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Mergers; Shareholders are Encouraged to Contact the Firm – GLIBA, MR, PRNB, YIN
5 years ago - By: Barron's
- Mentions:
SNY
UBS
REGN
Sanofi Is Buying Principia Biopharma for $3.7 Billion. Why Wall Street Is Cheering the Deal.
5 years ago - By: Zacks Investment Research
- Mentions:
BRK
SNY
GOLD
Stock Market News for Aug 18, 2020
Please enable JavaScript to continue using this application.